{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:28:27Z","timestamp":1781760507544,"version":"3.54.5"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background\/objective<\/jats:title><jats:p>Hidradenitis suppurativa (HS) is a chronic inflammatory disease affecting apocrine gland areas, characterized by painful nodules and abscesses that may result in sinus tracts and scarring. The global prevalence of HS is increasing due to heightened awareness, improved diagnostic methods, rising obesity rates, and higher smoking prevalence. This study aimed to describe the epidemiological, clinical, and comorbid characteristics of HS patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>This retrospective descriptive cross-sectional study included 193 outpatients aged between 15 and 73\u202fyears who visited a tertiary HS clinic between 2017 and 2022. Demographic, clinical, and comorbid characteristics were recorded and analyzed using chi-square and ordinal regression methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean age was 34.5\u202f\u00b1\u202f12.1\u202fyears, with a mean disease duration of 5.9\u202f\u00b1\u202f6.7\u202fyears. According to the Hurley classification, 61.1, 24.4, and 14.5% were stages I, II, and III, respectively. Comorbidities were present in 48.2% of patients, with psychiatric disorders (19.2%), diabetes mellitus (14%), and hypertension (9.3%) being most common. Disease duration, smoking, male gender, and atypical localization were associated with increased disease severity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Geographic and cultural factors influence the prevalence, severity, and management of HS, necessitating tailored treatment. Effective management requires multidisciplinary screening for early detection and prevention of comorbidities, including psychiatric disorders, cardiovascular conditions, and metabolic syndrome.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1499509","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T12:42:10Z","timestamp":1736426530000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Demographic features, clinical characteristics, and comorbid relation in hidradenitis suppurativa: a population-based study"],"prefix":"10.3389","volume":"11","author":[{"given":"G\u00f6khan","family":"Kaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Pelin","family":"\u00d6zgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Kelahmeto\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Su K\u00fc\u00e7\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahide","family":"Onsun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.3390\/cells10082094","article-title":"Hidradenitis suppurativa: where we are and where we are going","volume":"10","author":"Scala","year":"2021","journal-title":"Cells"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.3390\/ijerph18116131","article-title":"Quality of life in hidradenitis suppurativa: an update","volume":"18","author":"Chernyshov","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s13555-020-00354-2","article-title":"Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice","volume":"10","author":"Tzellos","year":"2020","journal-title":"Dermatol Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/exd.14633","article-title":"Which hidradenitis suppurativa comorbidities should I take into account?","volume":"31","author":"Tzellos","year":"2022","journal-title":"Exp Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41702-019-0052-0","article-title":"Global prevalence of hidradenitis suppurativa and geographical variation\u2014systematic review and meta-analysis","volume":"4","author":"Phan","year":"2020","journal-title":"Biomed Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/ced.14478","article-title":"Clinical and demographic features of hidradenitis suppurativa: a multicentre study of 1221 patients with an analysis of risk factors associated with disease severity","volume":"46","author":"\u00d6zkur","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/1203475419887732","article-title":"Demographic and clinical features of hidradenitis suppurativa in Turkey","volume":"24","author":"Y\u00fcksel","year":"2020","journal-title":"J Cutan Med Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/bjd.19435","article-title":"The epidemiology of hidradenitis suppurativa","volume":"183","author":"Ingram","year":"2020","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000508787","article-title":"Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system","volume":"236","author":"Kokolakis","year":"2020","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e834","DOI":"10.3399\/BJGP.2022.0137","article-title":"Mapping opportunities for the earlier diagnosis of psoriasis in primary care settings in the UK: results from two matched case-control studies","volume":"72","author":"Abo-Tabik","year":"2022","journal-title":"Br J Gen Pract"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"adv32746","DOI":"10.2340\/actadv.v104.32746","article-title":"The disease burdens of self-diagnosed hidradenitis Suppurativa patients in Japan: a cross-sectional web-based survey","volume":"104","author":"Hayama","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000517017","article-title":"Metabolic disorders\/obesity is a primary risk factor in hidradenitis Suppurativa: an Immunohistochemical real-world approach","volume":"238","author":"Kaleta","year":"2022","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/ijd.17101","article-title":"Evaluating dietary considerations in hidradenitis suppurativa: a critical examination of existing knowledge","volume":"63","author":"Vural","year":"2024","journal-title":"Int J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.clindermatol.2023.08.022","article-title":"The genetic aspects of hidradenitis suppurativa","volume":"41","author":"Bali\u0107","year":"2023","journal-title":"Clin Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.det.2015.07.002","article-title":"The genetics of hidradenitis Suppurativa","volume":"34","author":"Ingram","year":"2016","journal-title":"Dermatol Clin"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/jid.2012.372","article-title":"\u03b3-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis","volume":"133","author":"Pink","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/jamadermatol.2023.2217","article-title":"Genetic variants associated with hidradenitis Suppurativa","volume":"159","author":"Sun","year":"2023","journal-title":"JAMA Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"adv00364","DOI":"10.2340\/00015555-3724","article-title":"Pain in hidradenitis Suppurativa: a cross-sectional study of 1,795 patients","volume":"101","author":"Krajewski","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/bjd.18210","article-title":"Periodic worsening, or flare, in hidradenitis suppurativa: the perspective of people with hidradenitis","volume":"182","author":"Sarfo","year":"2020","journal-title":"Br J Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/bjd\/ljac083","article-title":"Living with hidradenitis suppurativa: managing the pain","volume":"188","author":"Cowdell","year":"","journal-title":"Br J Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/life11010034","article-title":"Quality-of-life impairment among patients with hidradenitis Suppurativa: a cross-sectional study of 1795 patients","volume":"11","author":"Krajewski","year":"2021","journal-title":"Life (Basel, Switzerland)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000533739","article-title":"High unemployment rate in patients with hidradenitis Suppurativa despite high educational attainment","volume":"240","author":"Kearney","year":"2024","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/CCID.S111019","article-title":"Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment","volume":"10","author":"Napolitano","year":"2017","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.clindermatol.2023.08.019","article-title":"Ectopic presentation of hidradenitis suppurativa","volume":"41","author":"Fisher","year":"2023","journal-title":"Clin Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.jid.2018.04.001","article-title":"Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a gender. And age-adjusted population analysis","volume":"138","author":"Garg","year":"2018","journal-title":"J Invest Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jamadermatol.2020.5435","article-title":"Hidradenitis suppurativa in the pediatric population: an international, multicenter, retrospective, cross-sectional study of 481 pediatric patients","volume":"157","author":"Liy-Wong","year":"2021","journal-title":"JAMA Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e2022061049","DOI":"10.1542\/peds.2022-061049","article-title":"Hidradenitis suppurativa in pediatric patients","volume":"151","author":"Cotton","year":"2023","journal-title":"Pediatrics"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bjd\/ljad317","article-title":"Hidradenitis suppurativa tarda: defining an understudied elderly population","volume":"190","author":"van der Weijden","year":"2024","journal-title":"Br J Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.21037\/atm-20-1028","article-title":"Hidradenitis suppurativa and psychiatric comorbidities, suicides and substance abuse: systematic review and meta-analysis","volume":"8","author":"Phan","year":"2020","journal-title":"Ann Transl Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies","volume":"173","author":"Tzellos","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/ijd.17186","article-title":"Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large-scale, propensity-matched global retrospective cohort study","volume":"63","author":"Krajewski","year":"2024","journal-title":"Int J Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1159\/000514582","article-title":"Association between hidradenitis Suppurativa and inflammatory arthritis: a systematic review and Meta-analysis","volume":"237","author":"Almuhanna","year":"2021","journal-title":"Dermatology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.semarthrit.2018.03.010","article-title":"High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: a possible new extra-articular manifestation","volume":"48","author":"Rondags","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/jamadermatol.2019.0891","article-title":"Association of Hidradenitis Suppurativa with Inflammatory Bowel Disease: a systematic review and Meta-analysis","volume":"155","author":"Chen","year":"2019","journal-title":"JAMA Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","article-title":"Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian hidradenitis Suppurativa foundations","volume":"86","author":"Garg","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"adv6569","DOI":"10.2340\/actadv.v103.6569","article-title":"Pilonidal sinus disease is associated with severe hidradenitis Suppurativa in a Spanish cohort","volume":"103","author":"Ure\u00f1a-Paniego","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/12034754231223451","article-title":"Hidradenitis suppurativa patient referrals to a Canadian community dermatology practice: a retrospective chart review","volume":"28","author":"Johnston","year":"2024","journal-title":"J Cutan Med Surg"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/bjd.17508","article-title":"Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment","volume":"180","author":"Rondags","year":"2019","journal-title":"Br J Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000501771","article-title":"Could residents adequately assess the severity of hidradenitis suppurativa? Interrater and Intrarater reliability assessment of major scoring systems","volume":"236","author":"W\u0142odarek","year":"2020","journal-title":"Dermatology"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/ijd.16889","article-title":"Drivers of disease severity and burden of hidradenitis suppurativa: a cross-sectional analysis on 553 German patients","volume":"63","author":"Schultheis","year":"2024","journal-title":"Int J Dermatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1499509\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T12:42:13Z","timestamp":1736426533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1499509\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":41,"alternative-id":["10.3389\/fmed.2024.1499509"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1499509","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"article-number":"1499509"}}